IGI Laboratories closed its underwritten offering including over-allotment
option
10/07/2014 17:39
IGI Laboratories, Inc. had announced the closing of its previously announced underwritten public offering of shares of its common stock on 2nd June. It included all 697,500 shares subject to the underwriters' over-allotment option. After giving effect to the exercise of the over-allotment option, the Company sold an aggregate of 5,347,500 shares of common stock in the offering at a public offering price of USD 5 per share. The net proceeds of the offering are expected to be approximately USD 25.2 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. Roth Capital Partners and Oppenheimer & Co. acted as joint book-running managers for the offering. Craig-Hallum Capital Group, LLC is acting as a financial advisor to the Company.
10/07/2014 17:39
IGI Laboratories, Inc. had announced the closing of its previously announced underwritten public offering of shares of its common stock on 2nd June. It included all 697,500 shares subject to the underwriters' over-allotment option. After giving effect to the exercise of the over-allotment option, the Company sold an aggregate of 5,347,500 shares of common stock in the offering at a public offering price of USD 5 per share. The net proceeds of the offering are expected to be approximately USD 25.2 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. Roth Capital Partners and Oppenheimer & Co. acted as joint book-running managers for the offering. Craig-Hallum Capital Group, LLC is acting as a financial advisor to the Company.
